W. Dauer

Neurology · 2003–2008

A researcher in the Science corpus: 2 papers; trusts 3 researchers and is trusted by 9 researchers here, as inferred from the citation graph.

Subfields

• Neurology — 34 citations into it; #285 of 1,455 by trust here, #349 by citations
• Cellular and Molecular Neuroscience — 19 citations into it; #818 of 2,998 by trust here, #1,121 by citations
• Molecular Biology — 11 citations into it
• Cell Biology — 9 citations into it
• Epidemiology — 8 citations into it

Whom W. Dauer trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. M. Goedert
2. K. Wilkinson
3. M. Feany
4. H. Lashuel

Who trusts W. Dauer overall

1. T. Dawson
2. J. Bové
3. A. Schober
4. Kent C. Berridge
5. H. Ko
6. Delphine Prou
7. Valina L. Dawson
8. A. Navarro
9. S. Przedborski
10. C. Perier

Papers from W. Dauer's perspective

Ordered by how strongly the researchers W. Dauer trusts endorse each paper. Same corpus, a different order for every researcher.

1. A Drosophila model of Parkinson's disease (Nature)
2. Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease (Science)
3. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. (Science)
4. Chronic systemic pesticide exposure reproduces features of Parkinson's disease (Nature Neuroscience)
5. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. (Proceedings of the National Academy of Sciences of the United States of America)
6. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase (Nature Genetics)
7. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. (Proceedings of the National Academy of Sciences of the United States of America)
8. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. (Proceedings of the National Academy of Sciences of the United States of America)
9. Conformational properties of alpha-synuclein in its free and lipid-associated states. (Journal of Molecular Biology)
10. Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of α-Synuclein in the Nigrostriatal System (Journal of Neuroscience)

Their papers

• Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. (2008) — 604 citations
• Parkinson's Disease Mechanisms and Models (2003) — 5,377 citations